In addition, strong antigen-specific immune responses including enhanced T cell proliferation, interferon gamma (IFN-γ) production, and cytotoxic T lymphocyte mediated responses are induced by a nanoparticle-pulsed dendritic cell vaccine, which is promising for dendritic cell-based immunotherapy potentially against cancer. This evidence concerns the gene IFNG and cancer.